A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Personalis, Inc. stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 21,412 shares of PSNL stock, worth $89,288. This represents 0.03% of its overall portfolio holdings.

Number of Shares
21,412
Holding current value
$89,288
% of portfolio
0.03%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025

BUY
$3.51 - $6.64 $75,156 - $142,175
21,412 New
21,412 $75.2 Million

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $191M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Susquehanna Portfolio Strategies, LLC Portfolio

Follow Susquehanna Portfolio Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Portfolio Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Portfolio Strategies, LLC with notifications on news.